Thermo opens India clinical trial services facility

By Nick Taylor

- Last updated on GMT

Related tags: Clinical trial services, Clinical trial

Thermo Fisher Scientific has opened a clinical services facility in India, which will provide biopharma services to companies operating clinical trials.

From the $17m, 150,000 sq ft facility located in Ahmedabad in western India Thermo will offer packaging, global distribution and logistics management.

The services are aimed at companies looking to supply pharmaceutical samples to patients participating in clinical trials and have been designed with consideration to regulatory requirements.

Marijn Dekkers, president and CEO of Thermo, said: “We continue to make the investments required to grow our business – in this case expanding our capabilities to support growing clinical research and development markets in India​.

With the added capacity now available to us with this new facility, we can offer our customers a higher level of technology, quality and expertise to facilitate clinical trials that serve the needs of both local and multi-national pharmaceutical companies​.”

The opening of the facility complements Thermo’s existing clinical trial services facilities located in the US, Europe and Asia. It also expands on Thermo’s capacity in India, which has undergone considerable development since it first established its presence in 2000.

In 2005 Thermo opened a facility in Mumbai offering laboratory services. Since then this has been supplemented by facilities offering manufacturing, biospecimen storage, life sciences research and environmental analysis.

Thermo has also made two acquisitions to expand its presence in India. Last year the company bought Qualigens Fine Chemicals and this was added to earlier this year through the acquisition of Chemito.

By making these two acquisitions Thermo established itself as a supplier of laboratory chemicals and analytical instruments in India. The company now employees 600 people at its 20 facilities in the country.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Planning Your First-In-Human Trial

Planning Your First-In-Human Trial

Altasciences | 15-Jul-2022 | Technical / White Paper

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug. A successfully conducted FIH trial provides...

Related suppliers

Follow us


View more